S&P 500   4,970.78 (-0.81%)
DOW   37,927.86 (+0.40%)
QQQ   416.58 (-1.61%)
AAPL   165.24 (-1.08%)
MSFT   400.69 (-0.89%)
META   482.49 (-3.85%)
GOOGL   153.89 (-1.36%)
AMZN   174.97 (-2.37%)
TSLA   148.16 (-1.18%)
NVDA   792.58 (-6.39%)
AMD   148.15 (-4.47%)
NIO   3.83 (-4.25%)
BABA   69.03 (+0.22%)
T   16.45 (+0.73%)
F   12.11 (+0.41%)
MU   107.33 (-4.11%)
GE   148.98 (-2.59%)
CGC   8.02 (+2.43%)
DIS   112.39 (-0.04%)
AMC   3.18 (+8.90%)
PFE   25.88 (+1.93%)
PYPL   62.09 (-0.02%)
XOM   119.91 (+1.17%)
S&P 500   4,970.78 (-0.81%)
DOW   37,927.86 (+0.40%)
QQQ   416.58 (-1.61%)
AAPL   165.24 (-1.08%)
MSFT   400.69 (-0.89%)
META   482.49 (-3.85%)
GOOGL   153.89 (-1.36%)
AMZN   174.97 (-2.37%)
TSLA   148.16 (-1.18%)
NVDA   792.58 (-6.39%)
AMD   148.15 (-4.47%)
NIO   3.83 (-4.25%)
BABA   69.03 (+0.22%)
T   16.45 (+0.73%)
F   12.11 (+0.41%)
MU   107.33 (-4.11%)
GE   148.98 (-2.59%)
CGC   8.02 (+2.43%)
DIS   112.39 (-0.04%)
AMC   3.18 (+8.90%)
PFE   25.88 (+1.93%)
PYPL   62.09 (-0.02%)
XOM   119.91 (+1.17%)
S&P 500   4,970.78 (-0.81%)
DOW   37,927.86 (+0.40%)
QQQ   416.58 (-1.61%)
AAPL   165.24 (-1.08%)
MSFT   400.69 (-0.89%)
META   482.49 (-3.85%)
GOOGL   153.89 (-1.36%)
AMZN   174.97 (-2.37%)
TSLA   148.16 (-1.18%)
NVDA   792.58 (-6.39%)
AMD   148.15 (-4.47%)
NIO   3.83 (-4.25%)
BABA   69.03 (+0.22%)
T   16.45 (+0.73%)
F   12.11 (+0.41%)
MU   107.33 (-4.11%)
GE   148.98 (-2.59%)
CGC   8.02 (+2.43%)
DIS   112.39 (-0.04%)
AMC   3.18 (+8.90%)
PFE   25.88 (+1.93%)
PYPL   62.09 (-0.02%)
XOM   119.91 (+1.17%)
S&P 500   4,970.78 (-0.81%)
DOW   37,927.86 (+0.40%)
QQQ   416.58 (-1.61%)
AAPL   165.24 (-1.08%)
MSFT   400.69 (-0.89%)
META   482.49 (-3.85%)
GOOGL   153.89 (-1.36%)
AMZN   174.97 (-2.37%)
TSLA   148.16 (-1.18%)
NVDA   792.58 (-6.39%)
AMD   148.15 (-4.47%)
NIO   3.83 (-4.25%)
BABA   69.03 (+0.22%)
T   16.45 (+0.73%)
F   12.11 (+0.41%)
MU   107.33 (-4.11%)
GE   148.98 (-2.59%)
CGC   8.02 (+2.43%)
DIS   112.39 (-0.04%)
AMC   3.18 (+8.90%)
PFE   25.88 (+1.93%)
PYPL   62.09 (-0.02%)
XOM   119.91 (+1.17%)
Free Trial
TSE:HBP

Helix BioPharma (HBP) Stock Price, News & Analysis

→ The A.I. story nobody is telling you (Read ASAP) (From TradeSmith) (Ad)
Free HBP Stock Alerts
C$0.18
-0.02 (-10.00%)
(As of 04/17/2024 ET)
Compare
Today's Range
C$0.18
▼
C$0.18
50-Day Range
C$0.17
▼
C$0.21
52-Week Range
C$0.15
▼
C$0.26
Volume
5,100 shs
Average Volume
15,673 shs
Market Capitalization
C$41.30 million
P/E Ratio
N/A
Dividend Yield
1.50%
Price Target
N/A
Stock AnalysisChartCompetitorsEarnings
HBP stock logo

About Helix BioPharma Stock (TSE:HBP)

Helix BioPharma Corp. operates as an immune-oncology company in Canada. It is developing L-DOS47 for the treatment of non-small cell lung cancer; and V-DOS47 that targets the vascular epithelial growth factor receptor 2. Helix BioPharma Corp. has collaboration agreements with Moffitt Cancer Center to investigate the pharmacodynamics of L-DOS47 and determine the benefits of combining L-DOS47 with immune checkpoint inhibitors; and with University Hospital Tuebingen to assess the therapeutic response of L-DOS47 in cancer models expressing CEACAM6, with advanced preclinical metabolic imaging. The company is headquartered in Toronto, Canada.

HBP Stock Price History

HBP Stock News Headlines

March 28, 2024 | ca.finance.yahoo.com
Canadian Investment Regulatory Organization Trading Halt - HBP
October 10, 2023 | finance.yahoo.com
Helix Biopharma Announces Upcoming Poster Presentation at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
April 19, 2024 | TradeSmith (Ad)
The A.I. story nobody is telling you (Read ASAP)
There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...
August 22, 2023 | stockhouse.com
Helix BioPharma Corp. Announces Closing of Private Placement of CAD $3 Million and Board Changes
June 14, 2023 | msn.com
Helix Biopharma GAAP EPS of -C$0.01
June 14, 2023 | finance.yahoo.com
Helix BioPharma Corp. Announces Fiscal 2023 Third Quarter Results
November 1, 2022 | proactiveinvestors.com
Helix BioPharma advances clinical development of lead candidate L-DOS47, but manages to decrease R&D expenses in 2022 fiscal year
November 1, 2022 | finance.yahoo.com
HELIX BIOPHARMA CORP. Announces Fiscal 2022 Year-End Results
April 19, 2024 | TradeSmith (Ad)
The A.I. story nobody is telling you (Read ASAP)
There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...
September 2, 2022 | proactiveinvestors.com
Helix BioPharma Corp names Dr Gabrielle Siegers as its head of research and development
September 2, 2022 | proactiveinvestors.com
Helix BioPharma names Dr Gabrielle Siegers as head of research and development
September 1, 2022 | finance.yahoo.com
Helix Biopharma Corp. Appoints Gabrielle M Siegers as the Head of Research & Development
August 30, 2022 | finance.yahoo.com
Helix Biopharma Corp. Announces Conclusion of Funding Agreement with Lind Global Macro Fund LP
June 14, 2022 | finance.yahoo.com
HELIX BIOPHARMA Corp. Announces Fiscal 2022 Third Quarter Results
June 3, 2022 | finance.yahoo.com
Helix Biopharma Corp. Announces Closure of Early Warrant Exercise Incentive Program | Raises Aggregate $3.21 Million
May 17, 2022 | finance.yahoo.com
Insiders may be rethinking their CA$3.0m Helix BioPharma Corp. (TSE:HBP) investment now that the company has lost CA$5.0m in value
April 22, 2022 | finance.yahoo.com
Jerzy Wilczewski Announces Acquisition of Common Shares of Helix Biopharma Corp.
April 18, 2022 | finanznachrichten.de
Helix BioPharma Corp.: Helix Biopharma Corp. Announces Appointment of Permanent CEO and Independent Board Members
April 18, 2022 | finance.yahoo.com
Helix Biopharma Corp. Announces Appointment of Permanent CEO and Independent Board Members
April 7, 2022 | finanznachrichten.de
Helix BioPharma Corp.: Helix Announces Board Resignation
March 22, 2022 | finanznachrichten.de
Helix BioPharma Corp.: Helix Biopharma Corp. Announces Management and Board Changes
March 22, 2022 | finance.yahoo.com
Helix Biopharma Corp. Announces Management and Board Changes
March 16, 2022 | finanznachrichten.de
Helix BioPharma Corp.: Helix Biopharma Corp. Announces Fiscal 2022 Second Quarter Results
March 16, 2022 | proactiveinvestors.com
Helix BioPharma announces sudden passing of interim CEO Slawomir Majewski
March 11, 2022 | apnews.com
Helix Biopharma Corp. Closes Private Placement and Announces Early Warrant Exercise Incentive Program and Extension of Warrant Exercise Period
March 11, 2022 | finance.yahoo.com
Helix Biopharma Corp. Closes Private Placement and Announces Early Warrant Exercise Incentive Program and Extension of Warrant Exercise Period
March 11, 2022 | finance.yahoo.com
CORRECTION: Helix Biopharma Corp. Closes Private Placement and Announces Early Warrant Exercise Incentive Program and Extension of Warrant Exercise Period
See More Headlines
Receive HBP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Helix BioPharma and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
4/19/2024
Next Earnings (Estimated)
4/24/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
TSE
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
TSE:HBP
CUSIP
N/A
CIK
N/A
Web
www.helixbiopharma.com
Phone
+1-416-9253232
Fax
N/A
Employees
9
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
C($0.03)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
C$-5,940,000.00
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
-111.88%

Debt

Debt-to-Equity Ratio
773.67
Current Ratio
1.46
Quick Ratio
1.04

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
229,440,000
Free Float
N/A
Market Cap
C$41.30 million
Optionable
Not Optionable
Beta
-0.74
7 Energy Stocks to Buy and Hold Forever Cover
7 Energy Stocks to Buy and Hold Forever

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Key Executives

  • Mr. Jacek Antas
    Chairman & CEO
  • Mr. Praveen Kumar Varshney F.C.A. (Age 58)
    FCA, FCPA, LLB, CFO & Corporate Secretary
  • Dr. Gabrielle M. Siegers M.A.
    Ph.D., Head of R&D
  • Dr. Srikanth Sola
    Chief Strategy Officer
  • Dr. Christof Boehler
    Chief Business Development Officer

Key Competitors

View All Competitors

HBP Stock Analysis - Frequently Asked Questions

How have HBP shares performed in 2024?

Helix BioPharma's stock was trading at C$0.21 at the start of the year. Since then, HBP shares have decreased by 14.3% and is now trading at C$0.18.
View the best growth stocks for 2024 here.

When is Helix BioPharma's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, April 24th 2024.
View our HBP earnings forecast.

What other stocks do shareholders of Helix BioPharma own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Helix BioPharma investors own include Lakeland Industries (LAKE), Liquidia (LQDA), Ovintiv (OVV), SIG (SHI), Green Organic Dutchman (TGOD), Zynerba Pharmaceuticals (ZYNE), American Airlines Group (AAL), Aurora Cannabis (ACB), Apollo Investment (AINV) and Aphria (APHA).

How do I buy shares of Helix BioPharma?

Shares of HBP stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (TSE:HBP) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
The A.I. story nobody is telling you (Read ASAP)
TradeSmith
The “Perfect Storm” for Gold
Gold Safe Exchange
Strange new buyer driving up gold
Stansberry Research
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS
Paradigm Press
Biden’s $374B Giveaway Into This Sector
DTI
Your Money is Not Safe
American Alternative
SHOCKING Crypto Leak…
Crypto 101 Media
Top 5 AI Stocks to Buy for 2024
Market Moving Trends